Genelux (GNLX) Other Working Capital Changes (2022 - 2026)
Genelux (GNLX) posted quarterly Other Working Capital Changes of -$87000.0 for Q1 2026, down 7.41% year-over-year from -$93960.0 in Q1 2025, and up 6.45% quarter-over-quarter from -$93000.0 in Q4 2025.
Genelux (GNLX) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Genelux's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$87000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 7.41% year-over-year to -$87000.0; the TTM figure through Mar 2026 stood at -$343000.0 (up 41.27% YoY), while the FY2025 annual figure was -$337000.0, up 48.23% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$87000.0, up from -$93000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $565000.0 in Q1 2024, with the low at -$4.5 million in Q4 2022.
- The 5-year median for Other Working Capital Changes is -$47000.0 (2023), against an average of -$389714.3.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes sank 85.87% in 2024, then jumped 51.22% in 2025.
- Genelux's Other Working Capital Changes stood at -$106000.0 in 2022, then gained by 13.21% to -$92000.0 in 2023, then tumbled by 85.87% to -$171000.0 in 2024, then soared by 45.61% to -$93000.0 in 2025, then advanced by 6.45% to -$87000.0 in 2026.
- Business Quant data shows GNLX's Other Working Capital Changes at -$87000.0 in Q1 2026, -$93000.0 in Q4 2025, and -$83000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Genelux | 120.53 Mn | 120.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Dec 31, 2025 | -93,000.00 |
| Dec 31, 2025 | -93,000.00 |
| Dec 31, 2025 | -93,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Jun 30, 2025 | -80,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Dec 31, 2024 | -171,000.00 |
| Dec 31, 2024 | -171,000.00 |
| Dec 31, 2024 | -171,000.00 |
| Sep 30, 2024 | -168,000.00 |
| Sep 30, 2024 | -168,000.00 |